news
logo-viroclinics

Parcom Capital has acquired the successful clinical research organisation Viroclinics Biosciences. Viroclinics believes Parcom is the perfect partner to help it realise its growth ambitions. Viroclinics employs more than 100 experts and works for clients across the world. The acquisition will give Viroclinics the opportunity to expand its fields of expertise and its portfolio of

MAIN Energie

The Spanish independent supplier of electricity and gas executes its internationalization strategy by entering the Dutch market with the acquisition of a controlling interest in MAIN Energie from Parcom Capital, a private equity fund operating in the Benelux

MGG Group

Parcom Capital today announces the acquisition of a majority stake in MGG Group, a cutting edge and high quality manufacturer of advanced aluminium sand‐castings and sub‐assemblies.

GoodHabitz

Parcom Capital has recently acquired a substantial interest in GoodHabitz, while also injecting capital into the business to facilitate international growth. GoodHabitz is a leading provider of online education in the Netherlands, with a reach of nearly one million users.

Bakkersland

Borgesius heeft van de Autoriteit Consument en Markt (ACM) goedkeuring gekregen voor de overname van Bakkersland Groep B.V. (Bakkersland). De ondernemingsraad heeft al eerder een positief advies gegeven. Hiermee zet Borgesius samen met Bakkersland een cruciale stap in de gedeelde ambitie om in het hele land lekker, vers én eerlijk brood te bakken. De bakker